Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens

Affiliations

• ¹ Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
• ² Department of Dermatology, Chiba University, Chiba, Japan.
• ³ Department of Pathology, Saitama Medical University International Medical Center, Saitama, Japan.
• ⁴ Department of Dermatology, Toranomon Hospital, Tokyo, Japan.